Dec 23, 2021 4:01pm EST NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2021
Sep 28, 2021 4:05pm EDT NeuBase to Participate at the Chardan 5th Annual Genetic Medicines Conference
Sep 15, 2021 4:05pm EDT NeuBase to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Sep 14, 2021 8:00am EDT NeuBase Therapeutics Appoints Anthony Rossomando, Ph.D. as Chief Technology Officer
Sep 01, 2021 4:05pm EDT NeuBase Therapeutics to Present Virtually at the H.C. Wainwright 23rd Annual Global Investment Conference
Aug 12, 2021 4:01pm EDT NeuBase Therapeutics Reports Financial Results for the Third Quarter of Fiscal Year 2021 and Recent Operating Highlights
Jun 08, 2021 12:30pm EDT NeuBase Therapeutics Demonstrates Functional Rescue in Myotonic Dystrophy Type 1 Model and Allele-Selective Inhibition of KRAS Mutations to Inhibit Tumor Growth
Jun 02, 2021 9:00am EDT NeuBase Therapeutics Announces Speakers for Virtual R&D Day Taking Place on June 8th
May 25, 2021 8:00am EDT NeuBase Therapeutics Appoints Dr. Kia Motesharei Chief Business and Strategy Officer